Declaration of competing financial interests

From the following article:

Rx-to-OTC switches: trends and factors underlying success

Laura A. Mahecha

Nature Reviews Drug Discovery 5, 380-386 (May 2006)

doi:10.1038/nrd2028

Declaration: Laura Mahecha is an employee of Kline & Co., an international consulting firm that through its Healthcare practice has been evaluating the US OTC and Rx pharmaceutical markets, including Rx to OTC switches, for nearly 40 years. The firm has conducted several proprietary switch analyses and has published many syndicated reports on switches for the industry.